N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease

scientific article published on 12 May 2020

N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814

External links are
P819ADS bibcode2020NatCo..11.2358L
P356DOI10.1038/S41467-020-16080-4
P932PMC publication ID7217877
P698PubMed publication ID32398649

P50authorSeung Hyun KimQ53176132
Hee-Jin KimQ59687975
Edward H SchuchmanQ92756224
Eunsoo YuQ94599567
P2093author name stringJu Youn Lee
Im-Sook Song
Seung Hoon Han
Min Hee Park
Min-Koo Choi
Cheol-Min Park
Hee Kyung Jin
Jae-Sung Bae
P2860cites workNLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 miceQ24604235
Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signalsQ24673096
Role of microglial m1/m2 polarization in relapse and remission of psychiatric disorders and diseasesQ27024102
Molecular basis of sphingosine kinase 1 substrate recognition and catalysisQ27684446
Mitochondrial dysfunction and oxidative stress in neurodegenerative diseasesQ28269333
Comprehensive behavioral analysis of voltage-gated calcium channel beta-anchoring and -regulatory protein knockout miceQ30407820
Microglial beclin 1 regulates retromer trafficking and phagocytosis and is impaired in Alzheimer's diseaseQ30545790
Prostaglandin signaling suppresses beneficial microglial function in Alzheimer's disease models.Q30634663
Pro-resolving lipid mediators are leads for resolution physiologyQ30829097
Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenesQ33204916
Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acidsQ33890830
Acid sphingomyelinase modulates the autophagic process by controlling lysosomal biogenesis in Alzheimer's diseaseQ33964297
Pro-resolving actions and stereoselective biosynthesis of 18S E-series resolvins in human leukocytes and murine inflammationQ34157528
Proresolving lipid mediators and mechanisms in the resolution of acute inflammationQ34411426
Resolution of inflammation is altered in Alzheimer's diseaseQ34765889
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and functionQ35172754
Microglial and macrophage polarization—new prospects for brain repairQ35394922
Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processingQ36376065
Endothelial cell-derived angiopoietin-2 is a therapeutic target in treatment-naive and bevacizumab-resistant glioblastomaQ36477818
Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 PhagocytosisQ36777563
Exogenous C2 Ceramide Suppresses Matrix Metalloproteinase Gene Expression by Inhibiting ROS Production and MAPK Signaling Pathways in PMA-Stimulated Human Astroglioma CellsQ36846961
ANGPTL4 deficiency in haematopoietic cells promotes monocyte expansion and atherosclerosis progressionQ37153606
C2-ceramide induces cell death and protective autophagy in head and neck squamous cell carcinoma cellsQ37645459
COX-2-derived endocannabinoid metabolites as novel inflammatory mediators.Q38200729
Neurological Disease as a Failure of Brain-Immune Crosstalk: The Multiple Faces of NeuroinflammationQ38951466
Modulators of microglial activation and polarization after intracerebral haemorrhageQ39317715
Ly6C(hi) Monocytes Provide a Link between Antibiotic-Induced Changes in Gut Microbiota and Adult Hippocampal NeurogenesisQ40664580
Microglia Polarization with M1/M2 Phenotype Changes in rd1 Mouse Model of Retinal DegenerationQ41453886
The 5‐lipoxygenase inhibitor, zileuton, suppresses prostaglandin biosynthesis by inhibition of arachidonic acid release in macrophagesQ41665336
Post-translational regulation of COX2 activity by FYN in prostate cancer cellsQ42847206
The TREM2-APOE Pathway Drives the Transcriptional Phenotype of Dysfunctional Microglia in Neurodegenerative DiseasesQ47568641
Microglia emerge as central players in brain diseaseQ47626576
Early and Late CNS Inflammation in Alzheimer's Disease: Two Extremes of a Continuum?Q50229256
Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.Q50531818
Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin.Q50720019
Neuronal SphK1 acetylates COX2 and contributes to pathogenesis in a model of Alzheimer's Disease.Q52584637
Neuropeptide Y Induces Hematopoietic Stem/Progenitor Cell Mobilization by Regulating Matrix Metalloproteinase-9 Activity Through Y1 Receptor in Osteoblasts.Q53119706
Microglia in Alzheimer's disease.Q53392184
Myeloid-derived suppressor cells control B cell accumulation in the central nervous system during autoimmunityQ58105796
The Regulatory Effects of Acetyl-CoA Distribution in the Healthy and Diseased Brain.Q64898882
A mechanistic hypothesis for the aspirin-induced switch in lipid mediator production by cyclooxygenase-2Q86980945
Aspirin Induces Lysosomal Biogenesis and Attenuates Amyloid Plaque Pathology in a Mouse Model of Alzheimer's Disease via PPARαQ89391648
Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlightQ91114669
P4510describes a project that usesImageJQ1659584
P433issue1
P921main subjectAlzheimer's diseaseQ11081
microgliaQ1622829
P304page(s)2358
P577publication date2020-05-12
P1433published inNature CommunicationsQ573880
P1476titleN-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer's disease
P478volume11